Retinoblastoma PDF
Retinoblastoma PDF
Retinoblastoma PDF
Retinoblastoma
GLOSSARY OF TERMS
TABLE
1 2 4 5 8 9 12 14 1 18 1 20 1 21
WHAT
IS
OF
CONTENTS
Aqueous Humor - watery fluid which bathes and nourishes the front of the eye External Beam Radiation - treatment which uses machines to give radiation to treat the tumors Fundus Drawing - map of the eye with tumor sketches drawn by the ophthalmologist Fundus Photographs - a photograph of the inside of the eye showing the retina Indirect Ophthalmoscope - instrument used to view the retina Iris - the colored portion of the eye Lamina Cribrosa - the zone in the optic nerve which represents the anatomical end of the eye Laser - light therapy used to treat small retinoblastoma tumor(s) Leukocoria - white pupillary reflex; cats eye reflex; the most common presenting sign of retinoblastoma Macula - the area of the retina responsible for central vision Metastasis - spread of a cancer to other parts of the body Ora Serrata - portion of the retina near the front part of the eye Optic Nerve - structure which carries impulses from the retina to the brain for interpretation Pediatric Oncologist - physician who specializes in cancer of children Prognosis - the overall outlook of treatment Pupil - black hole in the center of the iris Radioactive I-125 Plaque - a disc of radiation that is sewn to the eye to treat the retinoblastoma tumor(s) Retina - inner light-sensitive layer of the eye Retinoblastoma - a cancerous tumor of the retina of the eye Sclera - the outer protective white coating of the eye Strabismus - crossed eyes; second most common presenting sign of retinoblastoma Ultrasound - test which uses sound waves to view the eye and tumor(s) Unilateral Retinoblastoma - cancerous tumor(s) in the retina of one eye Vitreous Humor - the transparent gel that nourishes the back of the eye Vitreous Seeding - small balls of retinoblastoma that break off and extend into the vitreous
RETINOBLASTOMA?
OF THE
EYE
OF
SYMPTOMS
RETINOBLASTOMA
CAT Scan - test which uses x-rays to view the eyes and brain Choroid - the middle layer of the eye which contains blood vessels Chromosome 13 - the chromosome which has a missing piece that is responsible for the development of retinoblastoma Conjunctiva - thin membrane which lines the outside of the eye Cornea - clear portion of the front of the eye which bends light rays Cryotherapy - freezing treatment for small retinoblastoma tumor(s) Disc Diameter - horizontal size of the optic nerve head approximately 1-1.5 mm used as a reference point to measure tumors Enucleation - surgical removal of the eye
RETINOBLASTOMA
RETINOBLASTOMA
OF
CLASSIFICATION TREATMENT
OF
RETINOBLASTOMA
RETINOBLASTOMA
OF
RETINOBLASTOMA
TERMS
IRIS Medical gratefully acknowledges David H. Abramson, M.D., F.A.C.S. and Camille A. Servodidio, R.N., M.P.H. at the New York Hospital-Cornell University Medical Center for their efforts in researching and writing this brochure; and Barrett Haik, M.D. at the University of Tennessee, for his medical review of this brochure. This brochure was produced by
Equator - a circular reference zone approximately half way between the back of the eye and the front of the eye
Medical
I S
Richard S. LaRocco of the Cornell University Medical Center Department of Medical Art and Photography. 1997 Abramson/Servodidio. Published by IRIS Medical Instruments, Inc.
IRIS Medical Instruments, Inc., a subsidiary of IRIDEX Corporation 1212 Terra Bella Avenue, Mountain View, CA 94043-1842 650-962-8100
21
REFERENCES
IS RETINOBLASTOMA?
WHAT
Abramson, DH. Pediatric Emergency Casebook: Retinoblastoma. New York: Burroughs-Wellcome, 1985. pp 3-13. Abramson, DH. Retinoblastoma: Diagnosis and Management. CA. A Cancer Journal for Clinicians 1982. Volume 32, pp 130-142. Abramson, DH. The Diagnosis of Retinoblastoma. Bull NY Acad Med. 1988. Volume 64, pp 283 - 317. Abramson, DH, Ellsworth, RM. Ancillary Tests for the Diagnosis of Retinoblastoma. Bull NY Acad Med. 1980. Volume 56, pp 221-231. Abramson, DH, Ellsworth, RM, Kitchin, FD, Tung, G. Second Nonocular Tumors in Retinoblastoma Survivors; Are They Radiation Induced? Ophthalmology. 1984. Volume 91, pp 1351-1355. Abramson, DH, Dunkel, I, McCormick, BM. Neoplasms of the Eye, in Cancer Medicine, 4th Ed. Williams & Wilkins, Holland, J.ed 1996, pp 1517-1536. Abramson, DH, Servodidio, CA. Retinoblastoma in the First Year of Life. Ophthalmic Paediatr Genet. 1992; Volume 13, pp 191-203.
Char, DH, Hedges, TR 3rd, Norman, D. Retinoblastoma CT Diagnosis. Ophthalmology 1984. Volume 91, pp 1347-50. Donaldson, SS, Egbert, PR. Retinoblastoma. In: Pizzo, PA, Poplack, DG. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincott, 1989. pp 555-568. Dryja, TP. Assessment of Risk in Hereditary Retinoblastoma. In: Albert, DA and Jakobiec, FA. Principles and Practice of Ophthalmology. Philadelphia, PA: WB Saunders Co. 1996. Volume 5, pp 3270-3279. Eng, C, Li, FP, Abramson, DH, Ellsworth, RM, Wong, FL, Goldman, MB, Seddon, J, Tarbell, N & Boice, JD, Jr. Mortality From Second Tumors Among Long Term Survivors of Retinoblastoma. J Natl Cancer Inst. 1993. Volume 85, pp 11021103; 1121-1128. Gallie, BL, Dunn, JM, Hamel, PA, et al: How Do Retinoblastoma Tumors Form? Eye. 1992. Volume 6: pp 226-231. Grabowski, E, Abramson, DH. Retinoblastoma in Clinical Pediatric Oncology, 4th Edition, Fernbach, DJ & Vietti, TJ Editors.1991. Mosby Book, pp 427-436.
Murphree, AL, Villablanca, JG, Deegan, WF et al: Chemotherapy Plus Local Treatment in the Management of Intraocular Retinoblastoma. Arch Ophthalmol 1996. Volume 114, pp 1348-1356. Myers, CA, Abramson, DH. Radiation Protection: Choroidal Melanoma and Iodine-125 Plaques. JONT. 1988. Volume 7, pp 103-107. Romanella, A, Abramson, DH, Servodidio, CA. Unusual Presenting Signs of Retinoblastoma: A Case Study. JONT. 1991. Volume 10, pp 98-102. Servodidio, CA, Abramson, DH, Romanella, A. Retinoblastoma. Cancer Nursing. 1991. Volume 14, pp 117-123. Servodidio, CA, Abramson, DH. Genetic Teaching for the Retinoblastoma Patient. Insight. 1996. Volume 4, pp 20-3, 25. Shields, JA. Diagnosis and Management of Intraocular Tumors. St. Louis, Mo: C.V. Mosby Co. 1983. pp 437-532. Stello, J, Servodidio, CA. Radiation Therapy to the Eye. Memorial SloanKettering Cancer Center. 1993.
Retinoblastoma - (Reh-tin-oh-blast-oma)
is a cancer of one or both eyes which occurs in young children. There are approximately 350 new diagnosed cases per year in the United States. Retinoblastoma affects one in every 15,000 to 30,000 live babies that are born in the United States. Retinoblastoma affects children of all races and both boys and girls. The retinoblastoma tumor(s) originate in the retina, the light sensitive layer of the eye which enables the eye to see. When the tumors are present
in one eye, it is referred to as unilateral retinoblastoma, and when it occurs in both eyes it is referred to as bilateral retinoblastoma. Most cases (75%) involve only one eye (unilateral); the rest (25%) affect both eyes (bilateral). The majority (90%) of retinoblastoma patients have no family history of the disease; only a small percentage of newly diagnosed patients have other family members with retinoblastoma (10%). This booklet will help you understand the eye and the diagnosis and treatment of retinoblastoma.
20
found it very helpful to talk to other parents who share similar concerns. Some institutions have newsletters or formal support groups for parents of children with retinoblastoma. Finally, some institutions have programs which can make the childs return to school, home and the community a bit easier. Retinoblastoma is a life-threatening disease, but it is rarely a fatal one if treated appropriately. With
the correct treatment in the hands of an experienced ophthalmologist and appropriate follow-up both for eyes and for other cancers, the retinoblastoma patient has a very good chance of living a long, full, and happy life.
This chart shows the ages when parents and patients need to be aware of potential secondary cancers. Statistical analysis of over 40 years of cases has helped doctors recognize when and where these cancers develop. A reference card explaining this and other important information may be available at your doctors office.
19
18
Chemoreduction is the treatment of retinoblastoma with chemotherapy. Chemotherapy is given intravenously to your child. The drug passes through the blood stream and as it passes through the eye it causes the tumors to shrink within a few weeks. Chemotherapy, with one or more drugs, can be given once, twice, or more. Depending on the drug(s) and on the institution, the child may or may not be hospitalized during this process.
17
professionals may visit or care for the child, and children under twelve years old are not permitted to visit according to state guidelines. Patients take eye drops following plaque surgery for 3 to 4 weeks to prevent infection and inflammation. Following the plaque, long-term effects including cataracts, radiation retinopathy, and impaired vision may occur.
OF RETINOBLASTOMA
GENETICS
Ninety percent (90%) of all children who develop retinoblastoma are the first one in their family to have eye cancer. In 10% of retinoblastoma cases, however, a parent, grandparent, sibling, uncle, aunt, or cousin also had retinoblastoma. When retinoblastoma is passed from parent to child, the disease is usually, but not always, bilateral. Much work has been done in the past 10 years to figure out how a genetic abnormality causes cancer. The genetic patterns and their implications for you and your family are listed on page 7. Although it is not exactly understood why retinoblastoma occurs, it is known that in all of the cases this cancer is caused by an abnormality in chromosome 13, in which a piece of the chromosome is nonfunctional or missing. In 40% of the cases, the abnormality is present in every cell of the body including the eye and in 60% of cases, the abnormality is only found in the eye. Chromosome 13 is responsible for controlling retinal cell division. In children with
retinoblastoma retinal cell division continues unchecked, causing the retinal tumor(s). If a parent had bilateral retinoblastoma: If a parent has been treated for bilateral retinoblastoma and decided to have children, almost half (45%) of their children will develop retinoblastoma in their eyes. The child may have tumors in the eye at birth and may even have tumors that have spread through the body and into the brain at birth. On the other hand, many of these
shrink, because the pinkish-grey tumor mass is replaced by white calcium. Immediately after treatment, the skin may be sunburned or a small patch of hair may be lost in the back of the head from the beam exit position. Following external beam radiation, long-term effects can include cataract, radiation retinopathy (bleeding and exudates of the retina), impaired vision, and temporal bone suppression (bones on the side of the head which do not grow normally).
for retinoblastoma. It can be performed on an out-patient basis under local or general anesthesia. Lasers very effectively destroy smaller retinoblastoma tumors. This type of treatment is usually done by focusing light through the pupil onto and surrounding the cancers in the eye. Recently a new delivery system of the laser, called a DioPexy Probe, has enabled treatment of the cancer by
Cancer Facts
Cancerous growths have been discovered in Dinosaurs! Retinoblastoma was documented in children more than 2,000 years ago.
16
children do not have tumors in the eye at birth and develop them during the first few years of life. In our experience, all of these children begin to develop tumors in the eyes by 28 months and can continue to form them for 7 years. The overwhelming majority of children born to a parent with bilateral retinoblastoma will also have bilateral retinoblastoma, but about 15% will develop tumors in only one eye (unilateral retinoblastoma). Every time the bilateral retinoblastoma parent has another child, the chance of that child developing retinoblastoma is 45%. If a parent had unilateral retinoblastoma: If a parent had unilateral retinoblastoma, 7% to 15% of their offspring will have retinoblastoma. Interestingly, when a parent with unilateral retinoblastoma has a child who develops retinoblastoma, that child will usually (85% of the time) develop bilateral retinoblastoma. Many of these affected children do not have the tumor present at birth. But as with the situation above, if the child is going to develop retinoblastoma, they will begin to develop tumors by 28 months and can continue to form them for 7 years. Every time the unilateral retinoblastoma parent has another child, the chance of that child developing retinoblastoma is 7% to 15%. On the other
hand, 85% to 93% of the offspring of a unilateral retinoblastoma parent will not develop the disease. If neither parent had retinoblastoma: The situation where neither parent has had retinoblastoma is the most common and the most difficult to explain. Approximately one out of every 100 patients who has retinoblastoma appears to somehow destroy the tumor without treatment or perhaps has a form of the disease which is not capable of spreading. This is why both parents are encouraged to have a dilated retinal exam. One percent of the time there is evidence of a cured or limited form of retinoblastoma in the eye of a parent who was never aware of having had retinoblastoma and was never treated for it. In that case, 45% of that parents children will develop retinoblastoma. More confusing, and rarer is the possibility that a parent has the gene for retinoblastoma and can pass it on to his or her children without having any evidence of retinoblastoma in the eye. This is called the carrier state and it means that the parent carries the gene but not the disease. In this case, 45% of their children will be affected. Each of the examples listed here explains how a parent who never had retinoblastoma can have many children affected with bilateral retinoblastoma.
The prosthesis is made of plastic by an ocularist (an artist/technician) to look exactly like the other eye. Since the extraocular muscles are not attached to the prosthesis, it does not move as well as a natural eye. The prosthetic eye tends to move better up and down than it does side to side. And of course, the prosthetic eye does not see. Unfortunately, there is currently no way to transplant or replace an entire eye. When both eyes are involved, sometimes the more involved or worse eye is enucleated, while the other eye may be treated with one of the vision preserving treatments such as external beam radiation, plaque therapy, cryotherapy, laser treatment, and chemoreduction which are described below.
Tumors usually get smaller (regress) and look scarred after external beam radiation treatment but they rarely disappear completely. In fact, they may even become more obvious to the parent as they
1959
Dr. G.M. Schwickerath (Essen, Germany) First Case of Retinoblastoma treated with Photocoagulation (Laser)
1967
Dr. H. Lincoff (New York, USA) First Case of Retinoblastoma treated with Cryotherapy
1996
Dr. D. Abramson (New York, USA) First Case of Retinoblastoma treated with DioPexy Laser
1996
Dr. D. Abramson (New York, USA) First Case of Retinoblastoma treated with Local (Peri-ocular) Chemotherapy
15
TREATMENT OF RETINOBLASTOMA
The treatment of retinoblastoma is individualized for each patient. The treatment depends upon the age of the child, the involvement of one or both eyes, and whether or not the cancer has spread to other parts of the body. Almost all parents choose some form of treatment for their child. No treatment may mean that the child would die. Goals of treatment from most to least important ranking are: saving life, maintaining the eye and vision, and preserving cosmetic appearance. accompany the child to the operating room on the day of surgery and may be present until the child is anesthetized. The anesthesiologist will place a mask over the childs mouth and nose. Children usually fall asleep within a minute or two of breathing the anesthesia gases. In the operation, the entire eye is removed along with a long piece of the optic nerve as one specimen, and is sent to a pathologist for examination under a microscope. The eyebrow, lids and muscles of the eye are all left in place. Blinking, tearing and movement of the brow are not affected from this surgery. The operation takes less than an hour and is not painful. Children go home the same day and are usually examined in the office on the following day when post-operative instructions and care are explained. A ball of plastic, rubber or coral is placed where the eye had been so there is no cavity or hole. After the socket heals, it will look like the tissue on the inside of the lip. The child is fit for a prosthesis or false eye approximately 3 weeks after the operation.
1933
Dr. Foster-Moore (London, England) First Case of Retinoblastoma treated with Radioactive plaque
The most common situation is where neither parent has the gene for retinoblastoma but has a child born with retinoblastoma. If the parents are
genetically normal, the chance of another child having retinoblastoma is 1 in 15,000 to 1 in 20,000.
If Parent Was
This chart shows the likelihood of a parent to give the retinoblastoma to a child. A reference card explaining this and other important information may be available at your doctors office.
Chance of next sibling having retinoblastoma Focality Chance of offspring having retinoblastoma
Bilateral
45% affected 55% unaffected
Unilateral
7-15% affected 85-93% unaffected
Unaffected
<<1% affected 99% unaffected
Laterality
85% bilateral
15% unilateral
0%
85% bilateral
15% unilateral
0%
33% bilateral
67% unilateral
0%
100% multifocal
45%
45%
45%
45%
45%
45%
45%
7-15%
5%*
<1%*
<1%*
<1%
Retinoblastoma Facts
More than 95% of patients treated for retinoblastoma in the U.S. are cured
David H. Abramson, M.D., F.A.C.S.
Clinical Professor of Ophthalmology New York Hospital-Cornell University Medical Center Director, Robert M. Ellsworth Ophthalmic Oncology Center Memorial Hospital-Sloan Kettering Cancer Center New York Eye and Ear Infirmary Manhattan Eye, Ear and Throat Hospital Long Island College Hospital
More than 90% of patients retain at least one eye More than 80% of the children keep 20/20 vision Complete blindness is unusual in children who have been successfully treated for retinoblastoma
1903
Dr. H.Hilgartner (Texas, USA) First Case of Retinoblastoma treated with Radiation
1953
Dr. C. Kupfer (Maryland, USA) First Case of Retinoblastoma treated with Chemotherapy
14
GENETIC TESTING
The gene responsible for retinoblastoma has been identified and studied in great detail. Approximately 40% of patients have the abnormal gene responsible for retinoblastoma. There is now a test to detect the genetic defect. At the present time, the test is most accurate if the lab can study a specimen of tumor from the enucleated eye of the patient together with a blood sample. The test is technically more difficult when only blood specimens are available and is more straight forward in patients who have bilateral retinoblastoma than in patients with unilateral retinoblastoma. If the patient has the genetic abnormality, then other members of the family may
Retinoblastoma is a cancer
Retinoblastoma is the most common eye cancer in children Retinoblastoma is about as common as hemophilia
The average age for diagnosis of retinoblastoma when one eye is involved is 2.5 years There are 350 new cases of retinoblastoma per year in the U.S. and about 5,000 new cases worldwide
doctor or nurse about the usefulness and cost regarding the procedure involved with genetic testing.
Nursing Issues
Its okay to feel frightened and overwhelmed; this is a normal or common reaction to the diagnosis of cancer. You may find support by talking to other parents and children in the waiting room. Check with your local institution for support groups, one-on-one counseling, and newsletters. Many families have found these resources helpful. Children are remarkably adaptable. Your child may cope better than you!
FIFTH EXAMINATION: SIXTH EXAMINATION: SEVENTH EXAMINATION: EIGHTH EXAMINATION: NINTH EXAMINATION: TENTH EXAMINATION: ELEVENTH EXAMINATION: TWELFTH EXAMINATION: THIRTEENTH EXAM: FOURTEENTH EXAM:
This chart shows the examination schedule for children when one parent has retinoblastoma. A reference card explaining this and other important information may be available at your doctors office.
13
CLASSIFICATION OF RETINOBLASTOMA
The Reese-Ellsworth classification system was developed by two physicians as a method to predict prognosis of eyes treated by methods which save or preserve the eye. The higher the Group number in the system, the poorer the prognosis is for saving the eye. Reese-Ellsworth Classification for Retinoblastoma
Group I a. Solitary tumor, less than 4 disc diameters in size, at or behind the equator See Figure 1 b. Multiple size tumors, none over 4 disc diameters in size, all at or behind the equator See Figure 2 Group II a. Solitary tumor, 4 to 10 disc diameters in size, at or behind the equator b. Multiple size tumors, 4 to 10 disc diameters in size, all at or behind the equator Group III a. Any lesion anterior to the equator b. Solitary tumors larger than 10 disc diameters behind the equator Group IV a. Multiple tumors, some larger than 10 disc diameters b. Any lesion extending anteriorly to the ora serrata Group V a. Massive tumors involving over half the retina b. Vitreous seeding See Figure 3
Figure 1. Solitary tumor, less than 4 disc diameters in size, at or behind the equator
OF RETINOBLASTOMA
DIAGNOSIS
Recently, a staging system was developed to group retinoblastoma tumors confined to the eye and those tumors which spread outside of the eye and in other parts of the body. This system is referred to as the Abramson Staging System for Retinoblastoma. The Abramson Staging System for Retinoblastoma
1. Intraocular disease a. Retinal tumors b. Extension into choroid c. Extension up to lamina cribrosa d. Extension into sclera 2. Orbital disease a. Orbital tumor 1. Suspicious (pathology of scattered episcleral cells) 2. Proven (biopsy proven orbital tumor) b. Local nodal involvement 3. Optic nerve disease a. Tumor beyond lamina but not up to cut section b. Tumor at cut section of optic nerve 4. Intracranial metastasis a. Positive CSF only b. Mass CNS section 5. Hematogenous metastasis a. Positive marrow/bone lesions b. Other organ involvement
When there is a family history of retinoblastoma, newborn babies should be examined in the nursery at birth by an ophthalmologist, or an eye doctor. When there is no family history, it is frequently the parents who notice leukocoria or strabismus and bring their child in for an examination. Often the general ophthalmologist refers the child to an ophthalmologist who specializes in children with retinoblastoma and other cancers of the eye. The ophthalmic examination by the specialist is best done under general anesthesia. Some very young and older patients can be examined without general anesthesia; this decision is made by the ophthalmologist. When the examination is performed without general anesthesia, the child is placed on his or her back and is wrapped in a sheet like a mummy to restrict the movement of the childs arms and legs. Dilating drops (which sting for approximately 30 seconds after they are placed in the eye) are placed into both eyes prior to the examination. These drops dilate the pupils of the eyes and allow the ophthalmologist to view the retina. Sometimes numbing drops are also placed in both eyes to numb the
Ophthalmic examination for retinoblastoma
Figure 2. Multiple size tumors, none over 4 disc diameters in size, all at or behind the equator
surface of the eye. If the child is to be examined under anesthesia, the anesthesiologist will put the child to sleep by placing a mask over his or her mouth or nose. A tube may also be placed in the childs throat to aid breathing and an intravenous line may be started. In order
12
that permits a view of the retina, to determine the presence of tumors. A lid speculum or metal clip is placed between the eyelids to help keep the childs eye open. During the examination, the ophthalmologist uses a Q-tip or a metal scleral indentor (which looks like a pen with a flattened tip) to press on the scleral surface of the eye to push the most forward portions of the retina into view. Because the child is under anesthesia and his or her eye is numbed, they experience little or no discomfort from this process. A sketch, or fundus drawing, is made of the
Retinal drawing of retinoblastoma
for the tumor(s) in the eye. Future examinations will be based on these original drawings and photographs; new drawings and photographs may be sketched and taken at each follow-up visit. Ultrasound examination, which uses sound waves to penetrate and outline structures in the eye, confirms that retinoblastoma tumors are present and determines their thickness or height. Black and white polaroids of the ultrasound images may be taken initially and during the follow-up visits. An X-ray test called a CAT scan, Computed Axial Tomography, is also performed to determine if there is any tumor outside of the eye or in the brain (right). An MRI, Magnetic Resonance Imaging, which uses magnetic waves to image the eyes, the orbits, and the brain, may also be performed. Children who are diagnosed with retinoblastoma are also seen by a pediatric oncologist (childrens cancer physician). The pediatric oncologist determines whether there is a cancer anywhere else in the childs body. A physical examination and sometimes blood tests, a spinal tap (to see if there are cancer cells in the central nervous system), and a bone marrow biopsy (a sample of the blood cells taken from the bone) are performed by a pediatric oncologist.
CT Scan of retinoblastoma
tumor(s) of the eye. Sometimes photographs of the view through the indirect ophthalmoscope, fundus photos, are also taken of the tumor(s). Both the fundus drawing and the fundus photos serve as maps
to minimize the risks of anesthesia, the anesthesiologist will ask that the child not be given food or fluids for several hours before the examination. The child will usually fall asleep within a few minutes and the parent may stay until the child is anesthetized. If you have any doubts or questions about whether your child should have anesthesia, you should ask your ophthalmologist, anesthesiologist or nurse. The ophthalmologist views the retina with an indirect ophthalmoscope, a special instrument
Diagnostic Facts:
Retinoblastoma is diagnosed with the indirect ophthalmoscope, ultrasound, CT/MRI scans Biopsies are rarely necessary Anesthesia for examination and treatment may be necessary as often as every 2 weeks Examination of the parents may help in the diagnosis of the child
Ultrasound of retinoblastoma
10
11